Big capital flows into companies marrying AI with cancer treatments suggest early-stage clinical research is shifting its centre …
Big capital flows into companies marrying AI with cancer treatments suggest early-stage clinical research is shifting its centre …
New AI-powered system promises to reduce inefficiencies in trial recruitment by automating eligibility prediction
Leading biopharma companies are leveraging digital technologies and manufacturing expansions to enhance drug development and patient care.
Partnerships harnessing artificial intelligence are revolutionizing drug discovery, reducing timelines and improving candidate success rates.
Innovation, investment, and ideals intersected dramatically at the AI Action Summit—held 10–11 February at Paris’s Grand Palais. Co-chaired …
Sarepta Therapeutics reports encouraging Phase III trial data for Elevidys, its AAV-based gene therapy for Duchenne muscular dystrophy, …
Evaxion Biotech reaches a key milestone in melanoma research as all patients complete dosing in its AI-driven personalized …
Generative AI has produced a novel TNIK-inhibiting compound now advancing in phase 2a trials—an unprecedented milestone in drug discovery.
CMS approval of Tempus’s AI-powered ECG‑AF algorithm marks its inclusion under U.S. Medicare reimbursement, enabling broader access to …
Late-December 2024 sees the launch of Australia’s first government-backed clinical trial using AI-guided neuromodulation to tackle severe, treatment-resistant …
Already a subscriber? Log in